CN119110802A - 中环或大环苄基取代的杂环衍生物和相关用途 - Google Patents
中环或大环苄基取代的杂环衍生物和相关用途 Download PDFInfo
- Publication number
- CN119110802A CN119110802A CN202380037293.8A CN202380037293A CN119110802A CN 119110802 A CN119110802 A CN 119110802A CN 202380037293 A CN202380037293 A CN 202380037293A CN 119110802 A CN119110802 A CN 119110802A
- Authority
- CN
- China
- Prior art keywords
- compound
- alkyl
- pharmaceutically acceptable
- present disclosure
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/16—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/06—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263315438P | 2022-03-01 | 2022-03-01 | |
| US63/315,438 | 2022-03-01 | ||
| US202363439477P | 2023-01-17 | 2023-01-17 | |
| US63/439,477 | 2023-01-17 | ||
| PCT/US2023/014275 WO2023167925A1 (en) | 2022-03-01 | 2023-03-01 | Medium- or macro-cyclic benzyl-substituted heterocycle derivatives and related uses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN119110802A true CN119110802A (zh) | 2024-12-10 |
Family
ID=85772026
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202380037293.8A Pending CN119110802A (zh) | 2022-03-01 | 2023-03-01 | 中环或大环苄基取代的杂环衍生物和相关用途 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20250236629A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4486748A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025507852A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240157067A (cg-RX-API-DMAC7.html) |
| CN (1) | CN119110802A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2023228830A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3245204A1 (cg-RX-API-DMAC7.html) |
| CL (1) | CL2024002576A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL315237A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024010608A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202400606A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023167925A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12503475B2 (en) | 2020-09-03 | 2025-12-23 | Centessa Pharmaceuticals (Uk) Limited | Bicyclic-heterocycle derivatives and their uses as orexin-2 receptor agonists |
| WO2022207935A1 (en) | 2021-04-02 | 2022-10-06 | Orexia Therapeutics Limited | 2-(3-ethynylbenzyl)-substituted heterocycle derivatives as orexin-2 agonists |
| EP4680611A1 (en) | 2023-03-16 | 2026-01-21 | Takeda Pharmaceutical Company Limited | Macrocyclic heterocycle compounds and use thereof |
| JP2026518313A (ja) | 2023-06-01 | 2026-06-04 | ハー・ルンドベック・アクチエゼルスカベット | スピロ大環状オレキシン2受容体アゴニスト |
| CN122374291A (zh) | 2023-12-12 | 2026-07-10 | 爱杜西亚药品有限公司 | 作为食欲素受体调节剂的芳基砜及砜酮衍生物 |
| WO2025132542A1 (en) | 2023-12-19 | 2025-06-26 | Idorsia Pharmaceuticals Ltd | Macrocyclic orexin agonists |
| US20260144795A1 (en) | 2024-11-27 | 2026-05-28 | H. Lundbeck A/S | Spiromacrocyclic orexin 2 receptor agonists |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5763263A (en) | 1995-11-27 | 1998-06-09 | Dehlinger; Peter J. | Method and apparatus for producing position addressable combinatorial libraries |
| US10428023B2 (en) | 2017-08-03 | 2019-10-01 | Takeda Pharmaceutical Company Limited | Heterocyclic compound and use thereof |
| PE20211700A1 (es) | 2019-01-31 | 2021-09-01 | Takeda Pharmaceuticals Co | Compuesto heterociclico y su uso |
| KR20260083444A (ko) * | 2019-11-25 | 2026-06-05 | 알케르메스,인코포레이티드 | 치환된 마크로사이클릭 화합물 및 관련 치료 방법 |
| CN116635393A (zh) * | 2020-09-03 | 2023-08-22 | 欧瑞夏治疗有限公司 | 中环或大环苄基取代的杂环衍生物及其作为食欲素-2受体激动剂的用途 |
-
2023
- 2023-03-01 WO PCT/US2023/014275 patent/WO2023167925A1/en not_active Ceased
- 2023-03-01 KR KR1020247032615A patent/KR20240157067A/ko active Pending
- 2023-03-01 EP EP23713207.1A patent/EP4486748A1/en active Pending
- 2023-03-01 IL IL315237A patent/IL315237A/en unknown
- 2023-03-01 TW TW112107384A patent/TW202400606A/zh unknown
- 2023-03-01 JP JP2024551975A patent/JP2025507852A/ja active Pending
- 2023-03-01 MX MX2024010608A patent/MX2024010608A/es unknown
- 2023-03-01 CA CA3245204A patent/CA3245204A1/en active Pending
- 2023-03-01 CN CN202380037293.8A patent/CN119110802A/zh active Pending
- 2023-03-01 AU AU2023228830A patent/AU2023228830A1/en active Pending
-
2024
- 2024-08-28 US US18/817,943 patent/US20250236629A1/en active Pending
- 2024-08-29 CL CL2024002576A patent/CL2024002576A1/es unknown
-
2025
- 2025-04-11 US US19/177,396 patent/US20250289828A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20240157067A (ko) | 2024-10-31 |
| TW202400606A (zh) | 2024-01-01 |
| US20250289828A1 (en) | 2025-09-18 |
| JP2025507852A (ja) | 2025-03-21 |
| MX2024010608A (es) | 2024-09-23 |
| CL2024002576A1 (es) | 2025-01-10 |
| EP4486748A1 (en) | 2025-01-08 |
| AU2023228830A1 (en) | 2024-09-12 |
| CA3245204A1 (en) | 2023-09-07 |
| US20250236629A1 (en) | 2025-07-24 |
| WO2023167925A1 (en) | 2023-09-07 |
| IL315237A (en) | 2024-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12503475B2 (en) | Bicyclic-heterocycle derivatives and their uses as orexin-2 receptor agonists | |
| CN116635393A (zh) | 中环或大环苄基取代的杂环衍生物及其作为食欲素-2受体激动剂的用途 | |
| TWI915407B (zh) | Apol1抑制劑及其使用方法 | |
| AU2023228830A1 (en) | Medium- or macro-cyclic benzyl-substituted heterocycle derivatives and related uses | |
| WO2025072451A1 (en) | Ras-pi3k inhibitors for the treatment of cancer and immunological diseases | |
| CN119156375A (zh) | 双环杂环衍生物和相关用途 | |
| TW202003466A (zh) | 人類整合素α4β7拮抗劑 | |
| TW202237597A (zh) | 新型egfr降解劑 | |
| TW201643169A (zh) | 作為s1p調節劑的螺-哌啶衍生物 | |
| TW202309051A (zh) | 食慾素受體促效劑及其用途 | |
| TW202417432A (zh) | 抗菌化合物 | |
| TW201422592A (zh) | β-分泌酶抑制劑 | |
| CN114761383A (zh) | 磺酰胺衍生物及其用途 | |
| KR20230083276A (ko) | 오토탁신 억제제 화합물 | |
| KR102865307B1 (ko) | 수용체 억제제, 이를 포함하는 약학적 조성물 및 그 용도 | |
| CN116940562B (zh) | 乙酰胺基-苯基苯甲酰胺衍生物及其使用方法 | |
| EA052303B1 (ru) | Средне- или макроциклические производные бензилзамещенного гетероцикла и связанные с ними применения | |
| TW202530205A (zh) | 經取代之芳基磺醯胺及其組合物及用途 | |
| TW202537962A (zh) | 抑制α-V β-1整合素 | |
| JP2025537242A (ja) | 含窒素スピロ環式化合物、医薬組成物及びその用途 | |
| HK1184153B (en) | Spiro-cyclic amine derivatives as s1p modulators |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |